[Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin].
Tadashi Nagai, Tohru Izumi, Kaoru Noborio, Masaaki Takatoku, T. Ohtsuki, Takashi Machii, Norio Komatsu, Keiya Ozawa
Abstract
Tadashi Nagai, Tohru Izumi, Kaoru Noborio, Masaaki Takatoku, T. Ohtsuki, Takashi Machii, Norio Komatsu, Keiya Ozawa
Abstract
The hairy cell leukemia prolymphocytic variant, a subtype of hairy cell leukemia, is an extremely rare disease, especially in Japan. We report a case in which treatment with 2'-deoxycoformycin (DCF) improved the clinical features of the disease. The patient, a 70-year-old female, was first treated with 2-chlorodeoxyadenosine, but showed only transient improvement in the hematological findings. DCF was then administered every week. Following the start of this treatment, the leukemia cell count rapidly decreased and the platelet count simultaneously increased. This effect of DCF has so far been long term. More clinical studies are needed to confirm the therapeutic value of DCF.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The hairy cell leukemia prolymphocytic variant, a subtype of hairy cell leukemia, is an extremely rare disease, especially in Japan. We report a case in which treatment with 2'-deoxycoformycin (DCF) improved the clinical features of the disease. The patient, a 70-year-old female, was first treated with 2-chlorodeoxyadenosine, but showed only transient improvement in the hematological findings. DCF was then administered every week. Following the start of this treatment, the leukemia cell count rapidly decreased and the platelet count simultaneously increased. This effect of DCF has so far been long term. More clinical studies are needed to confirm the therapeutic value of DCF.
Key concepts: Deoxycoformycin, Medicine, Hairy cell leukemia, Pentostatin, Prolymphocytic leukemia, Leukemia, Internal medicine, Cladribine